Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient.
Hasan
R
R
Clinical School, Level E9, Addenbrooke's Hospital, Cambridge, UK.
Van den Bogaerde
J
J
Forty
J
J
Wright
L
L
Wallwork
J
J
White
D J
DJ
D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology*; D006224:Cricetinae; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004546:Elapid Venoms / Q000627:therapeutic use; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D008647:Mesocricetus; D051381:Rats; D011919:Rats, Inbred Strains; D014183:Transplantation, Heterologous / Q000276:immunology*
D000910:Antibodies, Heterophile; D004546:Elapid Venoms; C016310:cobra venom factor; D016572:Cyclosporine; D003520:Cyclophosphamide